Skip to content
Home/Companies/Biotech/Capstan Therapeutics
CT

Capstan Therapeutics

Biotech·United States·Exited 2025·Held 3yr

Capstan Therapeutics is a healthcare company, headquartered in USA.

Entry
2022
Hold
3yr
Exit
2025
Est. EV
–

Who owns Capstan Therapeutics?

Capstan Therapeutics was owned by Leaps by Bayer through Leaps by Bayer (2015 vintage) from 2022 to 2025, exited via Trade Sale. Across its history, Capstan Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Leaps by Bayer
Most recent investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen
2 ownership periods · full history below

Key facts

HQUSA
SectorHealthcare

Ownership history

2 ownership periods

Active
Currently held by Mubadala Capital.
Leaps by Bayer
Leaps by BayerExited 2025
2022 · 2025 · Leaps by Bayer · 2015 · Evergreen
Trade Sale · to
MOIC
–
Mubadala Capital
Mubadala CapitalActive
present · Mubadala Capital Other Investments · Buyout
MOIC
–

More from Leaps by Bayer

Other portfolio companies in the same fund.

Celea Therapeutics
Active
BiotechUnited States· 2026
Leaf Agriculture
Active
ClimateTechUnited States· 2026
SonoThera
Active
BiotechUnited States· 2026
Souffle Therapeutics
Active
BiotechUnited States· 2025
WellTheory
Active
HealthTechUnited States· 2025
Boundless Bio
Exited 2024
BiotechUnited States· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings